Armour Thyroid Cost in Maryland 2026

What Armour Thyroid Actually Costs in Maryland

The price a Maryland patient pays for Armour Thyroid depends on three variables: whether they use insurance or pay cash, which pharmacy they choose, and whether they qualify for a savings program. At retail without any coupon, expect to pay between $75 and $110 per month for a standard 60 mg or 90 mg dose. Apply a GoodRx or similar coupon and that figure drops to roughly $50 to $70 per month at chains like CVS, Walgreens, and Giant Food Pharmacy.

Manufacturer List Price vs. Street Price

Allergan (now AbbVie) sets the wholesale acquisition cost at approximately $180 per month for Armour Thyroid. That number appears on pharmacy benefit manager invoices, but almost no cash-pay patient in Maryland actually pays it. The 2026 average cash-pay price across Maryland retail pharmacies is $85 per month, based on aggregated claims data from major discount-card platforms.

The gap between list price and street price exists because pharmacy discount cards negotiate directly with the dispensing pharmacy, bypassing the usual insurer markup layer.

How Strength Affects Cost

Higher-strength tablets cost proportionally more. A 30 mg prescription (common during dose titration) may run $40 to $55 per month cash, while a 180 mg prescription can reach $120 to $140 per month without a coupon. Ask your prescriber to write for the largest tablet that cleanly divides into your target dose. A scored 60 mg tablet split in half costs less than two 30 mg tablets.

Compounded Natural Desiccated Thyroid: The $40 Option

Licensed 503A compounding pharmacies in Maryland may prepare customized NDT formulations for individual patient prescriptions. The average price is approximately $40 per month, less than half the retail cash price for brand Armour Thyroid. Compounded NDT is not FDA-approved as a finished drug product, but it is legal to dispense in Maryland when a licensed 503A pharmacy compounds it based on a valid individual patient prescription. The FDA distinguishes 503A pharmacies (patient-specific compounds) from 503B outsourcing facilities (larger-scale production), and Maryland Board of Pharmacy rules align with that federal framework.

Patients considering compounded NDT should confirm the pharmacy holds a current Maryland Board of Pharmacy license and uses United States Pharmacopeia (USP)-grade desiccated thyroid powder.

Maryland Medicaid Coverage for Armour Thyroid

Maryland Medicaid (HealthChoice) covers Armour Thyroid for hypothyroidism, but the coverage requires prior authorization. This is a meaningful distinction: the drug is on the formulary, so coverage is not a matter of "if" but of process.

Prior Authorization Requirements

To obtain PA under Maryland Medicaid, the prescribing clinician typically must document:

• A confirmed diagnosis of hypothyroidism (ICD-10 E03.9 or specified subtype)
• That levothyroxine monotherapy was trialed and either failed to control symptoms or was not tolerated
• The proposed dose and expected duration of therapy

The PA review is handled by the patient's managed care organization (MCO). Maryland HealthChoice enrollees are assigned to one of six MCOs, each with slightly different internal PA forms, but all must follow the same formulary coverage rules set by the Maryland Department of Health.

What to Do If PA Is Denied

A denial is not final. Maryland Medicaid enrollees have the right to a clinical appeal and, if needed, a fair hearing before an administrative law judge. Denials are often overturned when the prescriber submits peer-reviewed evidence that NDT improved symptoms in patients who remained symptomatic on levothyroxine alone. Hoang et al. (J Clin Endocrinol Metab, 2013, N=70) found that 49% of participants preferred desiccated thyroid extract over levothyroxine after a 16-week crossover trial, and patients on desiccated thyroid lost an average of 0.9 kg more than those on levothyroxine (1). That study is a reasonable supporting document for a PA appeal letter.

Maryland Medicaid and Compounded NDT

Maryland Medicaid does not routinely reimburse compounded medications unless a specific medical necessity exception is granted. For most HealthChoice enrollees, brand Armour Thyroid with PA is the covered path; compounded NDT would generally be an out-of-pocket cost.

Private Insurance Coverage in Maryland

Most commercial health plans sold in Maryland cover Armour Thyroid, though formulary placement and cost-sharing vary. The drug is classified as a thyroid hormone replacement agent (pharmacological class: thyroid hormones) and is not considered experimental by any major payer for the indication of hypothyroidism.

Tier Placement and Copays

• Tier 1 (preferred generic): Levothyroxine sits here on most plans.
• Tier 2 (preferred brand): Some Blue Cross Blue Shield of Maryland and Aetna plans place Armour Thyroid here, with copays around $30 to $50 per month.
• Tier 3 (non-preferred brand): More common placement. Copays range from $60 to $90 per month, with some plans applying a coinsurance percentage instead.

Patients on high-deductible health plans (HDHPs) may pay full cash price until they meet their deductible, which for a 2026 individual HDHP in Maryland can be as high as $1,650. In that scenario, a discount card may cost less than running the claim through insurance until the deductible resets.

Step Therapy Requirements

Several Maryland commercial plans require documented failure of levothyroxine before approving Armour Thyroid. Maryland enacted step-therapy reform legislation (House Bill 65, 2018) that limits how long insurers can require step therapy before allowing an override, and mandates that exceptions be granted when the prescribing clinician documents medical necessity. If your plan's step-therapy requirement is blocking access, your prescriber can request a step-therapy exception under this state law.

The HealthRX Maryland NDT Access Decision Framework: When a Maryland patient faces an insurance barrier for Armour Thyroid, the clinical team evaluates four paths in order. First, submit PA with levothyroxine trial documentation. Second, if denied, file a step-therapy exception under Maryland HB 65 (2018). Third, if the commercial exception fails, calculate whether the Allergan savings card or a discount card reduces the cost below the copay. Fourth, if cost remains prohibitive, evaluate candidacy for 503A compounded NDT at roughly $40 per month.

How the Allergan (AbbVie) Savings Card Works in Maryland

The manufacturer offers a savings program that can reduce the out-of-pocket cost of branded Armour Thyroid for eligible commercially insured patients. The savings card is not available to patients enrolled in federal or state government programs, including Maryland Medicaid or Medicare Part D.

For eligible patients, the card may lower the copay to as little as $25 per month. Eligibility rules, maximum annual benefit, and card terms change periodically. Patients should verify current terms directly at the AbbVie patient assistance website or ask their pharmacy to run the BIN/PCN numbers on the card before assuming a specific price.

Cash-pay patients (no insurance at all) are not eligible for the manufacturer savings card in its standard form, but may qualify for the AbbVie patient assistance program if their household income falls below program thresholds.

Compounded Natural Desiccated Thyroid: Legality in Maryland

Compounding NDT is legal in Maryland when performed by a pharmacy holding a valid Maryland Board of Pharmacy license operating under 503A rules. The FDA does not prohibit compounding of desiccated thyroid for individual patients, provided the pharmacy is not producing commercially available finished drug products in bulk or selling compounded copies of commercially available drugs without a patient-specific prescription.

503A vs. 503B: What Maryland Patients Need to Know

A 503A pharmacy compounds drugs based on individual prescriptions for specific patients. These are the community or specialty compounding pharmacies a patient or prescriber contacts directly. Maryland has several licensed 503A pharmacies that compound NDT, and a prescriber with a valid Maryland DEA registration and state license may write a prescription for compounded desiccated thyroid.

A 503B outsourcing facility produces larger volumes under FDA oversight and sells to health systems. 503B facilities are not typically the source for individual patient NDT compounds.

The FDA's guidance on compounding, available at FDA.gov, specifies that compounding pharmacies must not prepare drug products that are essentially copies of commercially available drugs unless there is a documented clinical difference (such as a unique dosage strength or formulation need). A prescriber documenting that a patient requires a specific strength not available in the commercial Armour Thyroid lineup (e.g., 45 mg) provides a legitimate basis for compounded NDT.

Quality Considerations

Unlike FDA-approved Armour Thyroid, compounded NDT is not subject to the same batch-release potency testing requirements. Patients and prescribers should ask the compounding pharmacy for Certificates of Analysis (COAs) confirming thyroid hormone content per lot (2). Patients with atrial fibrillation history, coronary artery disease, or osteoporosis should discuss potency variability risk with their physician before switching from a brand product to a compounded formulation.

Telehealth Prescribing of Armour Thyroid in Maryland

Maryland permits telehealth prescribing of Armour Thyroid. A licensed Maryland physician, nurse practitioner, or physician assistant may evaluate a patient via synchronous audio-video telehealth and issue a valid prescription for Armour Thyroid without an in-person visit, provided they establish a valid patient-provider relationship under Maryland law.

What the Telehealth Visit Should Include

A clinically appropriate telehealth evaluation for Armour Thyroid typically covers:

• Review of a recent TSH, free T4, and free T3 panel (most providers require labs drawn within the prior 90 days)
• Symptom review including fatigue, cold intolerance, weight changes, hair loss, and cognitive symptoms
• Cardiac history screen (tachyarrhythmia, angina) given that excessive thyroid hormone raises cardiovascular risk
• Current medication list to check for interactions (e.g., calcium, iron, and cholestyramine all reduce NDT absorption)

The American Thyroid Association's 2014 guidelines on hypothyroidism management state: "Evidence-based medicine can guide therapeutic decisions, but the needs and preferences of individual patients must also be considered."(3) That standard applies equally in telehealth settings.

Post-Visit Lab Monitoring

After starting or adjusting Armour Thyroid, most clinicians recheck TSH and free T3 at 6 to 8 weeks. The T3 component of desiccated thyroid is absorbed faster than the T4 component, which can produce a transient post-dose free T3 peak. Some clinicians draw the 6-to-8-week lab 4 hours after the morning dose to capture that peak; others draw fasting and pre-dose. Standardizing the draw timing across visits produces more comparable data.

The Cheapest Way to Get Armour Thyroid in Maryland: A Practical Comparison

| Option | Approximate Monthly Cost | Notes | |---|---|---| | Retail cash price (no coupon) | $85 | Average across MD pharmacies, 2026 | | GoodRx / RxSaver coupon, retail | $50 to $70 | Varies by pharmacy and strength | | Maryland Medicaid (with PA) | $0 to $4 copay | Requires prior authorization | | Commercial insurance, Tier 2 | $30 to $50 copay | Depends on plan | | Allergan savings card (insured) | As low as $25 | Commercially insured only; verify current terms | | 503A compounded NDT | ~$40 | Legal in MD; confirm pharmacy license | | AbbVie patient assistance program | $0 | Income-based; no insurance required |

For a cash-pay patient who does not qualify for Medicaid and is not commercially insured, the realistic lowest price is approximately $40 per month via a licensed 503A compounding pharmacy. For a commercially insured patient with step-therapy cleared, the Allergan savings card can bring the cost to $25 per month.

Clinical Background: Why Some Patients Choose Armour Thyroid Over Levothyroxine

Armour Thyroid contains both T4 (levothyroxine) and T3 (liothyronine) derived from desiccated porcine thyroid. The human thyroid produces both hormones, with roughly 80% of circulating T3 arising from peripheral conversion of T4 and 20% secreted directly. Some patients with hypothyroidism have impaired T4-to-T3 conversion, often due to polymorphisms in the deiodinase enzyme DIO2 (4).

The Hoang Trial Evidence

In the crossover trial by Hoang et al. (J Clin Endocrinol Metab, 2013, N=70), patients were randomized to 16 weeks of desiccated thyroid extract versus 16 weeks of levothyroxine. At the end of the study, 49% preferred desiccated thyroid extract, 19% preferred levothyroxine, and 33% had no preference. Patients on desiccated thyroid extract lost an average of 0.9 kg more. Both groups achieved similar TSH levels (1). This is the most-cited randomized controlled trial supporting patient-preference data for NDT.

T3 Content and Dosing Considerations

Each grain (60 mg) of Armour Thyroid provides 38 mcg of T4 and 9 mcg of T3. Because T3 has a shorter half-life (approximately 1 day vs. 7 days for T4), some patients notice an energy surge in the first 2 to 4 hours after the morning dose and a slight dip in the afternoon. Splitting the daily dose (morning and early afternoon) can smooth this curve, though the FDA-approved label supports once-daily dosing. Patients should not take Armour Thyroid within 4 hours of calcium supplements, iron, antacids, or cholestyramine, as absorption drops significantly (5).

TSH Targets on Desiccated Thyroid

Standard levothyroxine targets aim for TSH between 0.5 and 2.5 mIU/L in most non-pregnant adults under 65. On desiccated thyroid, clinicians often see TSH at the lower end of the reference range or mildly suppressed, with free T3 in the upper third of the reference range. The American Association of Clinical Endocrinologists (AACE) notes that individualized TSH targets are appropriate, particularly in patients with persistent symptoms on levothyroxine monotherapy (6).

Maryland-Specific Pharmacy Considerations

Which Pharmacies Stock Armour Thyroid in Maryland

Major chains including CVS, Walgreens, Rite Aid, and Giant Food Pharmacy stock Armour Thyroid, but availability of less-common strengths (15 mg, 240 mg, 300 mg) may require a 24-to-48-hour special order. Independent pharmacies and specialty compounding pharmacies are more reliably stocked across the full strength range.

90-Day Supply and Mail-Order Savings

Ordering a 90-day supply through a mail-order pharmacy typically reduces per-unit cost by 15% to 20% compared to monthly retail fills. Most Maryland commercial plans allow 90-day mail-order fills for maintenance medications. Maryland Medicaid also permits 90-day fills for stable patients under its pharmacy benefit rules.

Switching Between Manufacturers

Armour Thyroid (AbbVie/Allergan) is the most widely available branded desiccated thyroid in Maryland. NP Thyroid (Acella Pharmaceuticals) is a therapeutically similar product that some Maryland pharmacies carry and that may price differently under certain insurance formularies. The two products are not AB-rated as therapeutically equivalent by the FDA, so a pharmacist cannot substitute one for the other without prescriber authorization. If your prescription specifies "Armour Thyroid," that is what will be dispensed unless the prescriber amends the order.